GENE ONLINE|News &
Opinion
Blog

Sanofi
Trials & Approvals Sanofi
Sanofi’s Rare Disease Drug Granted First-Ever FDA Approval for the Condition
2022-09-01
Trials & Approvals Hemophilia A
Sanofi’s Treatment for Hemophilia A has a Concrete FDA Decision Date
2022-08-30
Trials & Approvals Oncology
Sanofi Abandons SERD Candidate After Second Breast Cancer Clinical Trial Blow
2022-08-18
China Sanofi
Sanofi Invests in Innovent to Gain Stronger Foothold in China
2022-08-05
Trials & Approvals Sanofi
Sanofi and Regeneron Post Positive Results from Child Throat Disease Trial
2022-07-15
Trials & Approvals siRNA
Sanofi’s siRNA Therapy Reduces Bleeds in Hemophilia, Meets Primary Endpoint
2022-07-12
Funding
Sanofi Launches Nonprofit Brand To Distribute Medicines to Low-Income Countries
2022-07-05
COVID-19 FDA
FDA Panel Suggests Redesigning Vaccines to Target Omicron Variants, Pfizer & Sanofi Share Booster Updates
2022-06-29
Trials & Approvals European Commission
Sanofi’s New Pompe Disease Treatment Wins Approval in Europe
2022-06-29
Trials & Approvals Eczema
FDA OKs First Biologic for Children Under 5 With Moderate-to-Severe Atopic Dermatitis
2022-06-08
Trials & Approvals Hemophilia A
Sanofi and Sobi Receive Breakthrough Therapy Designation for Hemophilia A Drug
2022-06-02
Regulatory FDA
Sanofi’s Trial to Make Cialis Available Over-the-Counter Meets FDA Hold
2022-05-31
Licensing Sanofi
Emerging NY Biotech Furthers Sanofi’s CNS Therapeutics
2022-04-22
China Antibody
Sanofi Bets $2.5 billion on Adagene to Make Antibodies Safer
2022-03-03
China Cholesterol
Innovent’s PCSK-9 Antibody Meets Primary Endpoints in Two Phase 3 Studies
2022-02-18
1 2 3 4
LATEST
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top